Acta Neuropharmacologica ›› 2016, Vol. 6 ›› Issue (5): 45-52.DOI: 10.3969/j.issn.2095-1396.2016.05.007
Previous Articles Next Articles
Zhang Hai-wei,Zhang Li
Online:
2016-10-26
Published:
2017-01-03
Contact:
张力,男,教授,硕士生导师;研究方向:神经药理学;Tel:+86-313-4029188,E-mail:hbnulzhang@126.com
About author:
张海威,男,硕士研究生;研究方向:神经药理学;E-mail:hwzhang1057@163.com
Supported by:
国家自然科学基金项目(No.81274005),河北省研究生创新资助项目(No.CXZZSS2017146)
Zhang Hai-wei,Zhang Li. Research Progress on Pinocembrin:Potential Therapeutic Applications and Action Mechanisms[J]. Acta Neuropharmacologica, 2016, 6(5): 45-52.
Add to citation manager EndNote|Ris|BibTeX
URL: http://actanp.hebeinu.edu.cn/EN/10.3969/j.issn.2095-1396.2016.05.007
[1]C Flavia Massaro Inoz, M Katouli, Tanja Grkovic, et al. Anti-staphylococcal activity of C-methyl flavanones from propolis of Australian stinglessbees (Tetragonula carbonari-a)and fruit resins of Corymbia torelliana(Myrtaceae)[J].Fitoterapia, 2014, 03: 024.[2]Carolina F Danert, Catiana Zampini, Roxana Ordonez, et al. Nutritional and functional properties of aqueous and hydroalcoholic extracts from Argentinean propolis[J].Nat Prod Commun, 2014, 9(2): 167-170.[3]R.D.Vargas-Sánchez, A.M. Mendoza-Wilson, R.R.Balandran-Quintana, et al. Study of the molecular structure and chemical reactivity of pinocembrin by DFT calculations[J].Comput Theor Chem,2015,1057:21-27. [4]WU Jun-jun, Zhang Xia, Dong Ming-sheng, et al. Stepwise modular pathway engineering of Escherichia colifor efficient one-step production of (2S)-pinocembrin[J].J Biothchnol, 2016, 231: 183-192. [5]WU Jun-jun, Zhang Xia, Dong Ming-sheng, et al. Efficient biosynthesis of (2S)-pinocembrin from d-glucose by integrating engineering central metabolic pathways with a pH-shift control strategy[J]. Bioresource Technol, 2016, 218: 999-1007. [6]Georgina N Diaz Napal, Sara M Palacios. Phytotoxicity of secondary metabolites isolated from Flourensia oolepis S.F.Blake[J].Chem Biodivers, 2013, 10(7): 1295-1304.[7]Yuan Yue, Yang Qing-yun, Tong Yuan-feng, et al. Synthesis and enantiomeric resolution of (+/-)-pinocembrin[J].J Asian Nat Prod Res, 2008, 10(9-10): 999-1002. [8]Muhammed A Saad, Rania Abdel Salam R M, Kenawy S A, et al. Pinocembrin attenuates hippocampal inflammation,oxidative perturbations and apoptosis in a rat model of global cerebral ischemia reperfusion[J].Pharmacological reports: PR, 2015, 67: 115-122.[9]Yang Zhi-hong, Sun Xiao, Yun Qi, et al. Uptake characteristics of pinocembrin and its effect on p-glycoprotein at the blood-brain barrier in vitro cell experiments[J].J Asian Nat Prod Res, 2012,14(1):14-21. [10]Yan Bei, Cao Guo-ying, Sun Tao-hua, et al. Determination of pinocembrin in human plasmaby solidphase extraction and LC/MS/MS: application to pharmacokinetic studies[J].Biomed Chromatogr, 2014, Doi: 10.1002/bmc.3186.[11]Wang Y J. National Institutes of Health Phase II study of pinocembrin injection to treat ischemic stroke[J/OL].ClinicalTrials.gov,2014.http://www.clinicaltrials.gov/ct2/show/NCT02059785?term=pinocembrin&rank=1. [12]Yang Zhi-hong, Liu Rui, Li Xiao-xiu, et al. Development and validation of a high-performance liquid chromatographic method for determination of pinocembrin in rat plasma: application to pharmacokinetic study[J].Pharm Biomed Anal, 2009, 49(5): 1277-1281.[13]Chiral L Sayre, Jody K Takemoto, Stephanie E Martinez, et al. Chiral analytical method development and application to preclinical pharmacokinetics of pinocembrin[J]. Biomed Chromatogr, 2013, 27(6): 681-684. [14]Liu Y L, Ho David K, John M Cassady, et al. Isolation of potential cancer chemopreventive agents from Eriodictyon californicum[J].J Nat Prod, 1992, 55(3): 357-363. [15]Bernd Weisshaar, Gareth I Jenkins. Phenylpropanoid biosynthesis and its regulation[J]. Curr Opin Plant Biol, 1998, 1(3): 251-257.[16]Masafumi Kaneko, Eui ILHwang, Yasuo Ohnishi, et al. Heterologous production of flavanones in Escherichia coli:potential for combinatorial biosynthesis of flavonoids in bacteria[J].J Ind Microbiol Biotechnol, 2003, 30(8): 456-461. [17]Yan Ya-jun, Abhijeet Kohli, Mattheos A G Koffas. Biosynthesis of natural flavanones in Saccharomyces cerevisiae[J].Appl Environ Microbiol, 2005, 71(9): 5610-5613. [18]Bong-Gyu Kim, Lee Hyejin, Joong-Hoon Ahn. Biosynthesis of pinocembrin from glucose using engineered Escherichia coli[J]. J Microbiol Biotechnol, 2014, 24(11): 1536-1541.[19]Dariush Mozaffarian, Emelia J Benjamin, Alan S Go, et al. Executive summary: heart disease and stroke statistics 2015 update: a report from the American Heart Association[J]. Circulation, 2015, 131(4): 434-441. [20]Shi Li-li, Chen Bai-nian, Gao Mei, et al. The characteristics of therapeutic effect of pinocembrin in transient global brain ischemia/reperfusion rats[J].Life Sci, 2011, 88(11-12): 521-528. [21]Gao Mei, Zhang Wen-cui, Liu Qing-shan, et al. Pinocembrin prevents glutamate-induced apoptosis in SH-SY5Y neuronal cells via decrease of bax/bcl-2 ratio[J].Eur J P-harmacol, 2008, 591(1-3): 73-79. [22]Hiroshi Izuta, Masamitsu Shimazawa, Shigemi Tazawa, et al. Protective effects of Chinese propolis and its component, chrysin, against neuronal cell death via inhibition of mitochondrial apoptosis pathway in SH-SY5Y cells[J]. J Agric Food Chem, 2008, 56(19): 8944-8953. [23]Liu R, Gao M, Yang Z H, et al. Pinocembrin protects rat brain against oxidation and apoptosis induced by ischemia-reperfusion both in vivo and in vitro[J].Brain Res,2008,1216:104-115. [24]Gao Mei, Zhu Shen-yin, Tan Chu-bing, et al. Pinocembrin protects the neurovascular unit by reducing inflammation and extracellular proteolysis in MCAO rats[J].J Asian Nat Prod Res, 2010, 12(5): 407-418.[25]Gao Mei, Liu Rui, Zhu Shen-yin, et al. Acute neurovascular unit protective action of pi-nocembrin against permanent cerebral ischemia in rats[J].J Asian Nat Prod Res, 2008, 10(5-6): 551-558. [26]Wang Shou-bao, Pang Xiao-bin, Gao Mei, et al. Pinocembrin protects rats against cerebral ischemic damage through soluble epoxide hydrolase and epoxyeicosatrienoic acids[J].Chin J Nat Med, 2013, 11(3): 207-213. [27]Jeffrey J Iliff, Nabil J Alkayed. Soluble epoxide hydrolase inhibition: targeting multiple mechanisms of ischemic brain injury with a single agent[J].Future Neurol, 2009, 4(2): 179-199.[28]Koichi Node, Huo Yu-qing, Ruan Xiu-lu, et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids[J].Science, 1999, 285(5431): 1276-1279. [29]Jorge H Capdevila, John R Falck. The CYP P450 arachidonic acid monooxygenases: from cell signaling to blood pressure regulation[J]. Biochem Biophys Res Commun, 2001, 285(3): 571-576. [30]John D Imig, Alexis N Simpkins, Marija Renic. Cytochrome P450 eicosanoids and cerebral vascular function[J]. Expert Rev Mol Med, 2011, 13: e7. [31]Jeremy Bellien, Robinson Joannides. Epoxyeicosatrienoic acid pathway in human health and diseases[J].J Cardiovasc Pharmacol, 2013, 61(3): 188-196. [32]Priyanka Sura, Radhakrishna Sura, Ahmed E Enayetallah, et al. Distribution and expression of soluble epoxide hydrolase in human brain[J].J Histochem Cytochem, 2008, 56(6): 551-559.[33]Sari A Jouihan, Kristen L Zuloaga, Zhang Wen-ri, et al. Role of soluble epoxide hydrolase in exacerbation of stroke by streptozotocin-induced type 1 diabetes mellitus[J].J Cereb Blood Flow Metab, 2013, 33(10): 1650-1656. [34]Zhang Wen-ri, Ines P Koerner, Ruediger Noppens, et al. Soluble epoxide hydrolase: a novel therapeutic target in stroke[J].J Cereb Blood Flow Metab, 2007, 27(12): 1931-1940.[35]Zhang Wen-ri, Takashi Otsuka, Nobuo Sugo, et al. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia[J].Stroke, 2008, 39(7): 2073-2078.[36]Jafar Sadik Shaik, Muzamil Ahmad, Li Wen-jin, et al. Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke[J].Am J Physiol Heart Circ Physiol, 2013, 305(11): H1605-H1613. [37]Christian Brenneis, Marco Sisignano, Ovidiu Coste, et al. Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation[J].Mol Pain, 2011, 7: 78. [38]Wu Cai-xia, Liu Rui, Gao Mei, et al. Pinocembrin protects brain against ischemia/reperfusion injury by attenuating endoplasmic reticulum stress induced apoptosis[J].Neurosci Lett, 2013, 546: 57-62. [39]Meng Fan-rui, Liu Rui, Gao Mei, et al. Pinocembrin attenuates blood-brain barrier injury induced by global cerebral ischemia-reperfusion in rats[J].Brain Res, 2011, 1391: 93-101. [40]Muhammed A Saad, Rania M Abdel Salam, Sanaa A Kenawy, et al. Pinocembrin attenuates hippoca-mpal inflammation, oxidative perturbations and apoptosis in a rat model of global cerebral ischemia reperfusion[J].Pharmacol Rep, 2015, 67(1): 115-122.[41]Shi Li-li, Chen Bai-nian, Gao Mei, et al. The characteristics of therapeutic effect of pinocembrin in transient global brain ischemia/reperfusion rats[J].Life Sci, 2011, 88(11-12): 521-528. [42]Denise M Boudreau, Gregory F Guzauskas, Chen Er, et al. Cost-effectiveness of recombinant tissuetype plasminogen activator within 3 hours of acute ischemic stroke: current evidence[J].Stroke, 2014, 45(10): 3032-3039. [43]Liu Rui, Wu Cai-xia, Zhou Dan, et al. Pinocembrin protects against beta-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis[J].BMC Med, 2012, 10: 105. [44]Liu Rui, Li Jin-ze, Song Jun-ke, et al. Pinocembrin improves cognition and protects the neurovascular unit in Alzheimer related deficits[J].Neurobiol Aging, 2014, 35(6):1275-1285. [45]Wang Yu-min, Miao Ying-chun, Aamina Zia Mir, et al. Inhibition of beta-amyloid-induced neurotoxicity by pinocembrin through Nrf2/HO-1pathway in SH-SY5Y cells[J]. J Neurol Sci, 2016, 368: 223-230.[46]Wang Yu-min, Gao Jun-hong, Miao Ying-chun, et al. Pinocembrin protects SH-SY5Y cells against MPP(+)-induced neurotoxicity through the mitochondrial apoptotic pathway[J].J Mol Neurosci, 2014, 53(4): 537-545. [47]Wang H Q, Wang Y M, Zhao L N, et al. Pinocembrin attenuates MPP+-induced neurotoxicity by the induction of heme oxygenase-1 through ERK1/2 pathway[J].Neurosci Lett, 2016, 612: 104-109.[48]Jin Xiao-hua, Liu Qian, Jia Li-li, et al. Pinocembrin attenuates 6-OHDA-induced neuronal cell death through Nrf2/ARE pathway in SH-SY5Y cells[J].Cell Mol Neurobiol, 2014, 35: 323-333..[49]Li Li, Yang Hai-guang, Yuan Tian-yi, et al. Rho kinase inhibition activity of pinocembrin in rat aortic rings contracted by angiotensin II[J].Chin J Nat Med, 2013, 11(3): 258-263. [50]Sang Hui, Yuan Na, Yao Shu-tong, et al. Inhibitory effect of the combination therapy of simvastatin and pinocembrin on atherosclerosis in ApoE-deficient mice[J].Lipids Health Dis, 2012, 11:166. [51]袁娜. 乔松素对ApoE-/-小鼠动脉粥样硬化影响的实验研究[D].泰山:泰山医学院,2010.[52]Yang Nana, Qin Shu-cun, Wang Meng-zan, et al. Pinocembrin,a major flavonoid in propolis, improves the biological functions of EPCs derived from rat bone marrow through the PI3K-eNOS-NO signaling pathway[J].Cytotechnology, 2013, 65(4): 541-551.[53]李伟,李冬娟,杨艳. 乔松素对脂多糖诱导的人脐静脉内皮细胞凋亡的影响[J].中国动脉粥样硬化杂志, 2010, 18(5): 351-354.[54]Lamiaa A Ahmed, Sherine M Rizk, Shohda A EL-Maraghy. Pinocembrin ex vivo preconditioni-ng improves the therapeutic efficacy of endothelial progenitor cells in monocrotaline-induced pulmonary hypertension in rats[J].Biochem Pharmacol, 2017, 138: 193-204.[55]Lanan Wassy Soromou, Chu Xiao, Jiang Lan-xiang, et al. In vitro and in vivo protection providedby pinocembrin against lipopolysaccharide-induced inflammatory responses[J]. Int Immunopharmacol, 2012, 14(1): 66-74. [56]Zhou Lu-ting, Wang Ke-jia, Li Ling, et al. Pinocembrin inhibits lipopolysaccharide-induced inflammatory mediators production in BV2 microglial cells through suppression of PI3K/Akt/NF-κB pathway[J].Eur. J. Pharmacol, 2015, 761: 211-216.[57]Soromou L W, Jiang L, Wei M, et al. Protection of mice against lipopolysaccha-ride-induced endotoxic shock by pinocembrin is correlated with regulation of cytokine secretion[J].J Immunotoxicol, 2014, 11(1): 56-61. [58]兰那. 乔松素抗金黄色葡萄球菌感染和抗炎作用及机制的研究[D].长春:吉林大学, 2013.[59]Sib S G, Shib S S, Venkatachalam S, et al. Pinocembrin attenuates lipopolysacc-haride-induced inflammatory responses in Labeorohita macrophages via the suppression of the NF-κB signalling pathway[J].Fish Shellfishi Immun, 2016, 56: 459-466.[60]Metzner J, Schneidewind E M, Friedrich E. Effect of propolis and pinocembrin on fungi[J].Pharmazie, 1977, 32(11): 730. [61]Araceli Sala, M Carmen Recio, Guillermo R Schinella, et al. Assessment of the anti-inflammatory activity and free radical scavenger activity of tiliroside[J].Eur J Pharmacol, 2003, 461(1): 53-61.[62]Metzner J, Schneidewind E M. Effect of pinocembrin on the course of experimental candida infections in mice[J].Mykosen, 1978, 21(8): 257-262. [63]Atac Uzel, Kadri Sorkun, Ozant Oncag, et al. Chemical compositions and antimicrobial activities of four different Anatolian propolis samples[J].Microbiol Res, 2005, 160(2): 189-195.[64]David R Katerere, Alexander I Gray, Robert J Nash, et al. Phytochemical and antimicrobial investigations of stilbenoids and flavonoids isolated from three species of Combretaceae[J].Fitoterapia, 2012, 83(5): 932-940. [65]Leticia M Estevinho, Ana Paula Pereira, Leandro Moreira, et al. Antioxidant and antimicrobial effects of phenolic compounds extracts of Northeast Portugal honey[J].Food Chem Toxicol, 2008, 46(12): 3774-3779. [66]Mariana Peralta, Maximiliano Calise, M Cecilia Fornari, et al. A prenylated flavanone from Dalea elegans inhibits rhodamine 6 G efflux and reverses fluconazole-resistance inCandida albicans[J]. Planta Med, 2012, 78(10): 981-987. [67]Ahmed G Hegazi, Faten K Abd EI Hady, Fayrouz A M Abd Allah. Chemical composition and anti-microbial activity of European propolis[J].Z Naturforsch C, 2000, 55(1-2): 70-75. [68] Yong K Park, Michel H Koo, Jose A S Abreu, et al. Antimicrobial activity of propolis on oral-microorganisms[J].Curr Microbiol, 1998, 36(1): 24-28. [69]Leticia Barrientos, Christian L Herrera, Gloria Montenegro, et al. Chemical and botanical characterization of Chilean propolis and biological activity on cariogenic bacteria Streptococcus mutans and Streptococcus sobrinus[J]. Braz J Microbiol, 2013, 44(2): 577-585. [70]Patrick Ruddock, Marijo Charland, Sandra Ramirez, et al. Antimicrobial activity of flavonoids from Piper lanceaefolium and other Colombian medicinal plants against antibiotic susceptible and resistant strains of Neisseria gonorrhoeae[J].Sex Transm Dis, 2011, 38(2): 82-88. [71]Soromou Lanan Wassy, Zhang Yu, Cui Yi-wen, et al. Subinhibitory concentrations of pinocembrin exert anti-Staphylococcus aureus activity by reducing alpha-toxinBexpression[J].J Appl Microbiol, 2013, 115(1): 41- 49. |
[1] | ZHANG Jian-mei, ZHANG Dan-shen. Advances in Research on Treatment of Ulcerative Colitis with Chinese and Western Medicine [J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 43-47. |
[2] | ZHANG Hao-nan, YANG Hui. Recent Advances in the Research of the Protective Effect of Natural Drugs on Cerebral Ischemia-Reperfusion Injury [J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(4): 14-20. |
[3] | JIN Shan, ZHANG Dan-shen. Research Progress of Lidocaine Transdermal Preparations [J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 16-20. |
[4] | BIAN Fang1,HOU Yan-ning2. Research Progress of the ATP Sensitive Potassium Channels in Neurodegenerative Diseases [J]. Acta Neuropharmacologica, 2017, 7(5): 52-58. |
[5] | QIN Xue-qing,YANG Zhi-hong,SUN Xiao-bo. A Review of Studies on Blood Brain Barrier in vitro Model [J]. Acta Neuropharmacologica, 2016, 6(1): 25-34. |
[6] | WANG Ying-ying, SONG Xiu-yun, WANG Qi, CHEN Nai-hong. Application of Natural Antioxidants in the Progress of Alzheimer's Disease [J]. Acta Neuropharmacologica, 2015, 5(6): 30-34. |
[7] | MEI Yan-fei, ZHANG Dan-shen. Pharmacological Actions and Therapeutic Applications of Tanshinone ⅡA [J]. ACTA NEUROPHARMACOLOGICA, 2014, 4(5): 55-64. |
[8] | MEI Yan-fei, ZHANG Li. Effects of Osthole on the Nervous System and its Pharmacokinetics [J]. ACTA NEUROPHARMACOLOGICA, 2014, 4(3): 57-64. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||